Clinical Trials Directory

Trials / Completed

CompletedNCT03871946

Fibromyalgia in Patient With Impaired Fasting Glucose

Status
Completed
Phase
Study type
Observational
Enrollment
146 (actual)
Sponsor
Hitit University · Academic / Other
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

To assess the frequency of fibromyalgia among women with impaired fasting glucose.

Detailed description

Objective: To assess the frequency of fibromyalgia among women with impaired fasting glucose. Materials and Methods: The sample was selected from the patients who applied to the Internal Medicine clinic and whose fasting blood glucose level were ≥100 and \<126 mg/dL in their routine examination \[Group1 \] and patients whose fasting blood glucose were less than 100 constituted the control group \[Group2 \]. Oral glucose tolerance test \[OGTT \] has been applied to patients with impaired fasting glucose and whose 2nd hour OGTT levels were under 140 has been included. Patients were evaluated in terms of fibromyalgia according to modified 2010 ACR Fibromiyalgia Criteria. Functional status was assessed by using the Fibromyalgia Impact Questionnaire \[FIQ \].

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESToral glucose tolerance test (OGTT)Implementation of OGTT: The patient was seated in a quiet room after 10-12 h of overnight fasting, and blood samples were drawn. Thereafter, 75 g glucose solution dissolved in 300 mL of water was administeredwithin 5 min. Two hours after this,another blood sample was drawn. During the test, the patient wasn't allowed to rest and eat, but not smoke.

Timeline

Start date
2015-08-15
Primary completion
2016-12-31
Completion
2016-12-31
First posted
2019-03-12
Last updated
2019-03-12

Source: ClinicalTrials.gov record NCT03871946. Inclusion in this directory is not an endorsement.